AU2001243701A1 - Radiographic assessment of tissue response to compounds - Google Patents

Radiographic assessment of tissue response to compounds

Info

Publication number
AU2001243701A1
AU2001243701A1 AU2001243701A AU4370101A AU2001243701A1 AU 2001243701 A1 AU2001243701 A1 AU 2001243701A1 AU 2001243701 A AU2001243701 A AU 2001243701A AU 4370101 A AU4370101 A AU 4370101A AU 2001243701 A1 AU2001243701 A1 AU 2001243701A1
Authority
AU
Australia
Prior art keywords
tissue
radiographic
compound
imaging agent
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243701A
Inventor
Jesse Salb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veritas Pharmaceuticals Inc
Original Assignee
Veritas Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veritas Pharmaceuticals Inc filed Critical Veritas Pharmaceuticals Inc
Publication of AU2001243701A1 publication Critical patent/AU2001243701A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/40—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4035—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for generating radiation specially adapted for radiation diagnosis the source being combined with a filter or grating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/42—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/4241—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector using energy resolving detectors, e.g. photon counting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/482—Diagnostic techniques involving multiple energy imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50—Clinical applications
    • A61B6/508—Clinical applications for non-human patients

Abstract

Radiographic system and method for noninvasively assessing the response of tissue to a compound, such as a therapeutic compound. In one embodiment, a non-radioactive, radio-opaque imaging agent accumulates in tissue in proportion to the tissue concentration of a predefined cellular target. The imaging agent is administered to a live organism, and after an accumulation interval, radiographic images are acquired. The image processing procedure isolates the radiographic density contributed solely by differential tissue accumulation of the imaging agent. A compound is administered to the organism, and after a selected interval, a second radiographic image of the tissue is acquired. Differences in radiographic density between the images reflect changes in the concentration of the cellular target that have occurred after administration of the compound. The system and method may be used to assess therapeutic efficacy of compounds in the drug discovery process, in clinical trials, and in the evaluation of clinical treatment.
AU2001243701A 2000-03-16 2001-03-16 Radiographic assessment of tissue response to compounds Abandoned AU2001243701A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19033000P 2000-03-16 2000-03-16
US60190330 2000-03-16
PCT/US2001/008663 WO2001067959A2 (en) 2000-03-16 2001-03-16 Radiographic assessment of tissue response to compounds

Publications (1)

Publication Number Publication Date
AU2001243701A1 true AU2001243701A1 (en) 2001-09-24

Family

ID=22700894

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001245805A Abandoned AU2001245805A1 (en) 2000-03-16 2001-03-15 Radiographic assessment of tissue response to compounds
AU2001243701A Abandoned AU2001243701A1 (en) 2000-03-16 2001-03-16 Radiographic assessment of tissue response to compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001245805A Abandoned AU2001245805A1 (en) 2000-03-16 2001-03-15 Radiographic assessment of tissue response to compounds

Country Status (5)

Country Link
EP (2) EP1263324B1 (en)
AT (1) ATE450201T1 (en)
AU (2) AU2001245805A1 (en)
DE (1) DE60140658D1 (en)
WO (2) WO2001067958A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6226352B1 (en) 1998-09-08 2001-05-01 Veritas Pharmaceuticals, Inc. System and method for radiographic imaging of tissue
US6723746B2 (en) 1998-09-08 2004-04-20 Veritas Pharmaceuticals, Inc. Functional radiographic imaging methods and agents
US6751290B2 (en) 1998-09-08 2004-06-15 Veritas Pharmaceuticals, Inc. Radiographic assessment of tissue after exposure to a compound
EP1263478A2 (en) * 2000-03-16 2002-12-11 Veritas Pharmaceuticals Functional radiographic imaging methods and agents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES381202A1 (en) 1969-06-27 1973-04-16 Nyegaard & Co As N-(2,4,6-triiodobenzoyl)-sugar amines
GB1548594A (en) 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
DE2909439A1 (en) 1979-03-08 1980-09-18 Schering Ag NEW NON-ionic x-ray contrast agents
FR2511871A1 (en) 1981-08-28 1983-03-04 Guerbet Sa PROCESS FOR INCREASING THE TOLERANCE OF OPACIFYING PRODUCTS AND OPACIFYING PRODUCTS THUS OBTAINED
US4716225A (en) 1984-12-27 1987-12-29 Georgetown University Radioopaque sugar derivatives and a method of metabolic mapping using the same
US5043152A (en) 1988-06-02 1991-08-27 Guerbet S.A. Novel iodinated non-ionic triiodobenzene compounds and contrast media containing them
EP0942000B1 (en) 1989-10-24 2004-06-23 Isis Pharmaceuticals, Inc. 2'-Modified oligonucleotides
US5610289A (en) 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
FR2687669B1 (en) 1992-02-24 1997-12-19 Guerbet Sa COMPOUNDS FOR USE IN CONTRAST PRODUCTS FOR RADIOGRAPHY.
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
US5408996A (en) * 1993-03-25 1995-04-25 Salb; Jesse System and method for localization of malignant tissue
WO1995003428A1 (en) 1993-07-20 1995-02-02 University Of Massachusetts Medical Center In vivo nucleic acid hybridization method
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
US5796862A (en) * 1996-08-16 1998-08-18 Eastman Kodak Company Apparatus and method for identification of tissue regions in digital mammographic images
IL121084A0 (en) * 1997-06-15 1997-11-20 Yeda Res & Dev Compositions and methods for diagnosis of tumors by X-ray imaging

Also Published As

Publication number Publication date
EP1263323A2 (en) 2002-12-11
WO2001067959A3 (en) 2002-02-14
ATE450201T1 (en) 2009-12-15
EP1263324A2 (en) 2002-12-11
AU2001245805A1 (en) 2001-09-24
EP1263324B1 (en) 2009-12-02
WO2001067958A2 (en) 2001-09-20
WO2001067958A3 (en) 2002-02-07
DE60140658D1 (en) 2010-01-14
WO2001067959A2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
RU2301066C2 (en) Method for treating gastrointestinal stromal tumor cases
Aigner et al. Bone marrow edema syndrome of the femoral head.
EP3435985B1 (en) Granulate formulation of 5-methyl-1-phenyl-2(1h)-pyridone and method of making the same
WO2004031348A3 (en) Method for convection enhanced delivery of therapeutic agents
JP2017501201A (en) Pharmaceutical composition comprising AZD9291
Van den Abbeele F18-FDG-PET provides early evidence of biological response to STI571 in patients with malignant gastrointestinal stromal tumors (GIST)
JP2016074728A (en) Use of 4-aminopyridine to improve neurocognitive and/or neuropsychiatric impairment in patients with demyelinating and other nervous system disorders
Etropolski et al. Dose conversion between tapentadol immediate and extended release for low back pain
Lecat et al. Multiple sclerosis and clinical gait analysis before and after fampridine: a systematic review
Wang et al. The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging
Hampson et al. Quadruple antimycobacterial chemotherapy in Crohn's disease: results at 9 months of a pilot study in 20 patients
AU2001243701A1 (en) Radiographic assessment of tissue response to compounds
JP2019514944A (en) Formulations and treatments with hydroxypyridonate actinide / lanthanide extracorporeal agents
Joseph et al. Radiotherapy in aggressive cutaneous pseudolymphoma: a case report and review of literature
Morrison et al. Penile calciphylaxis diagnosed with computed tomography.
Horwitz et al. Novel gastroretentive controlled‐release drug delivery system for amoxicillin therapy in veterinary medicine
RU2314055C1 (en) Method for treating nasopharyngeal cancer
JP2768559B2 (en) Diagnostic preparation for detection of Helicobacter Pylori
CN109091682A (en) 99mNew application of the Tc-3P-RGD2 in terms of predicting mela-noma of choroid transfer
Hepburn et al. Minocycline-induced black bone disease
JPH059116A (en) 3-oxygermylpropionic acid composition and cytopathic inhibitor consisting essentially of the same composition
JP2007523827A (en) Method for treating acute lymphoblastic leukemia with mixed leukemia gene rearrangement
Hollenhorst et al. Optimized radiation of pelvic volumes in the clinical setting by using a novel bellyboard with integrated gonadal shielding
US20230277567A1 (en) Fospropofol methods and compositions
Seto et al. Assessment of residual tumor viability in thymic carcinoma by sequential thallium-201 SPECT: comparison with CT and biopsy findings